2020
DOI: 10.1007/s12020-020-02494-z
|View full text |Cite
|
Sign up to set email alerts
|

Clinical application of a novel next generation sequencing assay for CYP21A2 gene in 310 cases of 21- hydroxylase congenital adrenal hyperplasia from India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 33 publications
1
13
0
Order By: Relevance
“…Compared with previous northern Indian published studies, none of our present cohorts had p.Arg340His mutation. [ 9 10 ] The high frequency of p.Pro31Leu mutations in this study is similar to the other published literature from India. The most common mutations identified in the other published Indian studies were Intron 2 (c.293-13A/C>G) mutation, p.Pro31Leu, and p.Ile173Asn.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…Compared with previous northern Indian published studies, none of our present cohorts had p.Arg340His mutation. [ 9 10 ] The high frequency of p.Pro31Leu mutations in this study is similar to the other published literature from India. The most common mutations identified in the other published Indian studies were Intron 2 (c.293-13A/C>G) mutation, p.Pro31Leu, and p.Ile173Asn.…”
Section: Discussionsupporting
confidence: 90%
“…Moreover, the prevalence of the above mutations is similar to the previously published studies from India. [ 8 9 10 11 ]…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…A few years ago, this technology was not applied to screen the CYP21A2 gene defects due to its high sequence identity with CYP21A2P which hampers the proper analysis of this genomic region 5 . However, recently some groups have found alternative ways to perform NGS for the CYP21A2 gene through a combination with other methods, such as Multiplex ligation-dependent probe amplification 8,9 . These genetic analysis strategies of the CYP21A2 gene with the NGS technology represent a promising tool for the future, opening the window to identify new variants while improving the diagnosis of CYP21A2 deficiency, and establishing a more reliable estimate of mutation frequencies.…”
Section: Introductionmentioning
confidence: 99%